Krebs Biochemicals Industries Ltd vs Natco Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 17, 2026

Key Highlights

The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 57.85 as of 15 May 15:30 . The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Natco Pharma Ltd changed from 34.2 on March 2021 to 7.6 on March 2025 . This represents a CAGR of -25.98% over 5 years The Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Natco Pharma Ltd changed from ₹ 15045 crore on March 2021 to ₹ 14287 crore on March 2025 . This represents a CAGR of -1.03% over 5 years The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Natco Pharma Ltd for the Dec '25 is ₹ 705.4 crore as compare to the Sep '25 revenue of ₹ 1463 crore. This represent the decline of -51.78% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Natco Pharma Ltd for the Dec '25 is ₹ 216.8 crore as compare to the Sep '25 ebitda of ₹ 679.2 crore. This represent the decline of -68.08% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Natco Pharma Ltd changed from ₹ 668.5 crore to ₹ 140.4 crore over 7 quarters. This represents a CAGR of -59.01% The Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Natco Pharma Ltd changed from 30.96 % on March 2021 to 5.8 % on March 2025 . This represents a CAGR of -28.46% over 5 years .

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.

About Natco Pharma Ltd

Natco Pharma Ltd Share Price Overview Natco Pharma Ltd share price history highlights how the stock has evolved across different market cycles.
It reflects both company-specific developments and broader trends in the healthcare sector.
As a participant in this sector, the Natco Pharma Ltd share price movement is often influenced by factors such as drug regulations, generic demand, and changes in investor sentiment. Tracking its historical performance helps investors understand how the Natco Pharma share price has responded to earnings growth, economic shifts, and key business milestones over time. Long-Term Performance The Natco Pharma share price history has shown strong growth over different years.
Over the last five years, Natco Pharma Ltd share has delivered a CAGR of approximately 33.3%. The Natco share price reflects an upward trend, with a period of short-term volatility linked to earnings-related cycles, sector-specific factors, and broader market-sentiment shifts. Impact of Corporate Actions on Natco Pharma Ltd Share Price When analysing Natco Pharma Ltd share price history, it is important to account for corporate actions such as stock splits, bonus issues, and dividend payouts.
These events can adjust the Natco Pharma share price without affecting the company’s underlying value. Using adjusted historical prices provides a more accurate representation of long-term performance and investor returns. Factors Influencing Natco Pharma Ltd Share The following are the factors that may influence the Natco Pharma Ltd share price: Earnings Performance: Fluctuations in earnings due to variations in sales performance, margin, and generic approvals may affect the Natco Pharma share price directly. Order Book and Deal Wins: New order bookings and timely deal executions may have an effect on Natco Pharma Ltd share price performance. Healthcare Sector Growth: Increased demand in generics and policy support can help the Natco Pharma share price grow significantly. International Demand: International demand, especially in oncology drugs, may have a positive effect on Natco Pharma Ltd share revenues. Input Costs: Variations in input costs, like APIs and chemicals, may have an effect on Natco Pharma share profits. Currency Movement: Exchange rate changes may impact Natco Pharma Ltd share price through export revenues and input costs. Market Sentiment: Broader market trends, investor confidence and perception about the company can affect Natco Pharma share price behaviour. Why Check Share Price History of Natco Pharma Ltd Share? Here’s why reviewing the Natco Pharma Ltd share price history can be useful: Understanding Long-Term Trends: Historical data shows how the Natco Pharma share price has moved across different market cycles. Understanding Volatility: Past Natco Pharma Ltd share price movements provide an idea of how the stock behaves during market fluctuations. Comparison with Peers: Comparing performance with other healthcare companies can provide additional clarity. Support Investment Decisions: Reviewing past patterns helps in forming a more balanced and informed perspective. How to Analyse Share Price History of Natco Pharma Ltd Share? To analyse the Natco Pharma share history, individuals can follow the steps given below: Start With the Trend: Check whether the Natco Pharma share price has generally moved upward or experienced phases of consolidation and correction. Identify Support and Resistance: Observe price levels where the share price has previously stopped falling ‘support’ or faced selling pressure ‘resistance’. Analyse Volume: Check whether price movements are supported by higher trading volumes because stronger volume can indicate improved market participation. Utilise Technical Analysis Tools: Simple technical analysis tools, such as the moving average, can help one determine the trend direction and momentum of the Natco Pharma Ltd share price. Track Key Developments: Monitor earnings announcements, deal wins, and news to connect Natco Pharma share price changes with business events. Check Multiple Timeframes: Considering both short and long-term charts may help individuals provide more clarity and understanding of Natco Pharma Ltd share price movements. .

FAQs for the comparison of Krebs Biochemicals & Industries Ltd and Natco Pharma Ltd

Which company has a larger market capitalization, Krebs Biochemicals & Industries Ltd or Natco Pharma Ltd?

Market cap of Krebs Biochemicals & Industries Ltd is 124 Cr while Market cap of Natco Pharma Ltd is 21,451 Cr

What are the key factors driving the stock performance of Krebs Biochemicals & Industries Ltd and Natco Pharma Ltd?

The stock performance of Krebs Biochemicals & Industries Ltd and Natco Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krebs Biochemicals & Industries Ltd and Natco Pharma Ltd?

As of May 17, 2026, the Krebs Biochemicals & Industries Ltd stock price is INR ₹57.85. On the other hand, Natco Pharma Ltd stock price is INR ₹1197.7.

How do dividend payouts of Krebs Biochemicals & Industries Ltd and Natco Pharma Ltd compare?

To compare the dividend payouts of Krebs Biochemicals & Industries Ltd and Natco Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.